Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)

Subscribe to Selected New Research on Trimethoprim-Sulfamethoxazole Combination

3208 relevant articles (386 outcomes, 390 trials/studies) found for this Drug

Description: This drug combination has proved to be an effective therapeutic agent with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.

Also Known As:

Co-Trimoxazole; Lescot; Bactrim; Centran; Septra; Septrin; Trimethoprim-Sulfamethoxazole; Abactrim; Bactifor; Biseptol; Biseptol-480; Centrin; Cotrimoxazole; Drylin; Eslectin; Eusaprim; Insozalin; Kepinol; Kepinol Forte; Metomide; Oriprim; Sulfamethoxazole-Trimethoprim Combination; Sulprim; Sumetrolim; TMP SMX; TMP-SMX; Trimedin; Trimethoprimsulfa; Trimezole; Trimosulfa; Biseptol 480; Biseptol480; Co Trimoxazole; Sulfamethoxazole Trimethoprim Combination; Trimethoprim Sulfamethoxazole; Trimethoprim Sulfamethoxazole Combination; Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine

Relationship Network

Drug Context: Research Results

Experts

1.	Craescu, Constantin T: 4 articles (02/2008 - 10/2003)
2.	Miron, Simona: 4 articles (02/2008 - 10/2003)
3.	Blouquit, Yves: 4 articles (02/2008 - 10/2003)
4.	Duchambon, Patricia: 4 articles (02/2008 - 10/2003)
5.	Mermin, Jonathan: 4 articles (09/2006 - 10/2004)
6.	Sowunmi, A: 4 articles (04/2006 - 09/2002)
7.	Adedeji, A A: 4 articles (04/2006 - 09/2002)
8.	Chierakul, Wirongrong: 3 articles (08/2007 - 10/2005)
9.	Peacock, Sharon J: 3 articles (08/2007 - 10/2005)
10.	Chaowagul, Wipada: 3 articles (08/2007 - 10/2005)

Related Diseases

1.	Infection 01/01/1998 - "Modern treatment options, including prophylaxis with trimethoprim-sulfamethoxazole and rIFN-gamma as well as early and aggressive anti-infection therapy, have improved the prognosis of this disease dramatically. " 01/01/2003 - "The infection was treated successfully with trimethoprim-sulfamethoxazole. " 01/01/1998 - "Cyclospora infections can be treated successfully with trimethoprim-sulfamethoxazole." 02/01/1989 - "The exclusive use of TMP/SMX produced a significant reduction in mortality (P less than 0.0001) and an absence of clinical signs of infection. " 05/01/1982 - "These data indicated that a mean dose of TMP/SMX 6.8/34 mg/kg/d divided into twice daily doses and given for six months was safe and effective in controlling RAOM infections in a high-risk pediatric population." Order ALL the reference details at left...
2.	Urinary Tract Infections (Urinary Tract Infection) 08/08/1990 - "In over 6 months of observation, postcoital administration of trimethoprim-sulfamethoxazole was highly effective in preventing recurrent urinary tract infections. " 03/01/1975 - "Colonization of the vaginal introitus with Enterobacteriaceae was cleared dramatically in women receiving trimethoprim-sulfamethoxazole for recurrent urinary tract infections. " 06/01/1985 - "Single-dose trimethoprim-sulfamethoxazole is as effective as ten-day treatment in women with symptoms suggestive of lower urinary tract infection and has no greater relapse rate." 01/01/2001 - "The aim of the study was to determine the efficacy of cotrimoxazole administration after urodynamic testing to prevent urinary tract infections. " 06/01/1988 - "Efficacy of five years of continuous, low-dose trimethoprim-sulfamethoxazole prophylaxis for urinary tract infection." Order ALL the reference details at left...
3.	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 11/01/1993 - "Trimethoprim-sulfamethoxazole administered orally daily or thrice weekly is highly effective for the prevention of Pneumocystis carinii pneumonia. " 01/01/2003 - "Cotrimoxazole is cheap and effective against a wide range of organisms, including Pneumocystis carinii pneumonia (PCP) which is an important cause of death and illness in the first year of life. " 10/01/2005 - "Prevention and treatment of Pneumocystis pneumonia with trimethoprim/sulfamethoxazole is effective in reducing this risk. " 07/01/1994 - "This preliminary study suggests that the efficacy of these regimens in preventing pneumocystis pneumonia, however, may be less than that of trimethoprim-sulfamethoxazole." 10/01/2003 - "Although several studies have reported that it is safe to discontinue secondary Pneumocystis carinii pneumonia (PCP) prophylaxis in patients infected with HIV who experience a sustained immune response as a result of antiretroviral therapy, we describe a patient who developed recurrent PCP <3 months after discontinuing trimethoprim-sulfamethoxazole prophylaxis. " Order ALL the reference details at left...
4.	Pneumonia (Pneumonitis) 01/01/2006 - "Cotrimoxazole is cheap and effective against a wide range of organisms, including Pneumocystis jiroveci pneumonia (PCP), which is an important cause of death and illness in the first year of life. " 11/21/2001 - "Chemotherapeutic prophylaxis is very effective in preventing P carinii pneumonia; the combination of trimethoprim-sulfamethoxazole remains the first-line agent for both therapy and prophylaxis. " 01/01/1984 - "Trimethoprim sulfamethoxazole is very effective in the prevention of Pneumocystis carinii pneumonitis. " 09/01/1979 - "Trimethoprim-sulfamethoxazole has been proven effective in the treatment and prevention of Pneumocystis carinii pneumonitis in lower animals and humans. " 01/01/2005 - "CONCLUSION: Both standard and double strength cotrimoxazole were equally effective in treating non-severe pneumonia. " Order ALL the reference details at left...
5.	Acquired Immunodeficiency Syndrome (AIDS) 03/30/2008 - "The intervention remained cost-effective in all sensitivity analyses including routine haematological and CD4% monitoring, varying starting age, AIDS status, cotrimoxazole formulation, efficacy duration and discount rates. " 11/01/2009 - "The preferred first line treatment is trimethoprim-sulfamethoxazole; however, second line treatments for those intolerant of this regimen have been primarily studied in patients with acquired immunodeficiency syndrome (AIDS). " 02/01/2006 - "The objective of this study was to assess the impact of medicines information on adherence to chronic co-trimoxazole therapy in low-literate HIV/AIDS patients. " 08/12/2005 - "Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis." 07/01/1995 - "A study showed that 86 percent of AIDS patients who had varying degrees of intolerance to the drug were successfully desensitized by a rapid method of oral TMP-SMX. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)
2.	Trimethoprim (Proloprim)
3.	Thymidine Monophosphate (TMP)
4.	Sulfamethoxazole
5.	Ampicillin (Omnipen)
6.	Amoxicillin (Wymox)
7.	Rifampin (Rifampicin)
8.	Ciprofloxacin (Cipro)
9.	Norfloxacin
10.	Chloramphenicol (Chloromycetin)

Related Therapies and Procedures

1.	Aftercare (After-Treatment)
2.	Transplants (Transplant)
3.	Transplantation (Transplant Recipients)
4.	Chemoprevention
5.	Drug Therapy (Chemotherapy)

Best Treatments:
Research Summary Report
on Infection

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 14726 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>